Retaglutide is a novel GLP-1 receptor agonist currently under study for the control of type 2 diabetes. This medication works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://zubairkuwg593516.shoutmyblog.com/37859132/trelaglutide-exploring-a-new-therapy-for-chronic-diseases